TickerHumSide-by-side comparison
Abbott Laboratories vs Stryker
As of Nov 11, 2026, P/E is 40.6x for Abbott Laboratories vs 33.9x for Stryker; P/S is 3.9x for Abbott Laboratories vs 4.6x for Stryker; revenue growth is 10.0% for Abbott Laboratories vs 7.9% for Stryker; operating margin is 13.8% for Abbott Laboratories vs 20.7% for Stryker.
What stands out
- Stryker keeps more of each sale as operating profit: 20.7% margin vs 13.8% for Abbott Laboratories.
- Stryker scores higher on TickerHum's ratings: 59/100 vs 48/100 for Abbott Laboratories.
Key metrics
| Metric | ABT | SYK |
|---|---|---|
| Price | $109.29 | $318.79 |
| Market cap | $189.28B | $121.36B |
| P/E | 40.6x (#2) | 33.9x (#1) |
| P/S | 3.9x (#1) | 4.6x (#2) |
| Revenue growth | 10.0% (#1) | 7.9% (#2) |
| Operating margin | 13.8% (#2) | 20.7% (#1) |
| Net margin | 9.7% (#2) | 13.8% (#1) |
| Debt / equity | 0.58 (#1) | 0.60 (#2) |
| 1-year return | -15.2% (#2) | -13.2% (#1) |
| Research score | 48/100 (#2) | 59/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Stryker Corporation (SYK) — Medical Devices